Literature DB >> 35721653

Pericarditis complicating COVID-19 infection: a report of two cases.

Zainab El Mir1, Hammam Rasras1, Falmata Laouan Brem1, Zakaria Bazid1,2, Nabila Ismaili1,2, Noha El Ouafi1,2.   

Abstract

COVID-19 infection is responsible for many complications, which can lead to a high risk of mortality. Respiratory manifestations are the most encountered, while that cardiovascular complications are classified as the most severe. We report two cases of COVID-19 infection complicated by pericarditis. In the absence of other etiology of pericarditis, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was considered as the behind cause. The treatment in these two cases was corticosteroids with colchicine, with good outcomes. In the presence of any cardiovascular symptoms, pericarditis related to COVID-19 should be suspected, in order to act swiftly and avoid complications as well as contamination. Copyright: Zainab El Mir et al.

Entities:  

Keywords:  COVID-19; Pericarditis; case report; myocarditis; pericardial effusion

Mesh:

Substances:

Year:  2022        PMID: 35721653      PMCID: PMC9167472          DOI: 10.11604/pamj.2022.41.229.28816

Source DB:  PubMed          Journal:  Pan Afr Med J


  9 in total

1.  [2015 ESC Guidelines for the diagnosis and management of pericardial diseases].

Authors:  Yehuda Adler; Philippe Charron; Massimo Imazio; Luigi Badano; Gonzalo Barón-Esquivias; Jan Bogaert; Antonio Brucato; Pascal Gueret; Karin Klingel; Christos Lionis; Bernhard Maisch; Bongani Mayosi; Alain Pavie; Arsen D Ristić; Manel Sabaté Tenas; Petar Seferovic; Karl Swedberg; Witold Tomkowski
Journal:  Kardiol Pol       Date:  2015       Impact factor: 3.108

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 3.  Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.

Authors:  Massimo Imazio; Antonio Brucato; George Lazaros; Alessandro Andreis; Mirko Scarsi; Allan Klein; Gaetano Maria De Ferrari; Yehuda Adler
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2020-09       Impact factor: 2.160

Review 4.  Approach to Acute Cardiovascular Complications in COVID-19 Infection.

Authors:  Lauren S Ranard; Justin A Fried; Marwah Abdalla; D Edmund Anstey; Raymond C Givens; Deepa Kumaraiah; Susheel K Kodali; Koji Takeda; Dimitrios Karmpaliotis; LeRoy E Rabbani; Gabriel Sayer; Ajay J Kirtane; Martin B Leon; Allan Schwartz; Nir Uriel; Amirali Masoumi
Journal:  Circ Heart Fail       Date:  2020-06-05       Impact factor: 8.790

Review 5.  [SARS-COV-2 myocarditis. An update].

Authors:  D Fard; R Huguet; A Koutsoukis; C Deguillard; A-S Tuffreau; J-F Deux; P Lim; E Teiger
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2020-10-08

6.  Pericardial effusion in patients with COVID-19: case series.

Authors:  François Sauer; Charlotte Dagrenat; Philippe Couppie; Gaelle Jochum; Pierre Leddet
Journal:  Eur Heart J Case Rep       Date:  2020-09-09

7.  Acute pericarditis revealing COVID-19 infection: Case report.

Authors:  Raid Faraj; Chifaa Belkhayat; Amine Bouchlarhem; Ghizlane El Aidouni; Houssam Bkiyar; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-01-21

Review 8.  Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.

Authors:  Chirag Bavishi; Robert O Bonow; Vrinda Trivedi; J Dawn Abbott; Franz H Messerli; Deepak L Bhatt
Journal:  Prog Cardiovasc Dis       Date:  2020-06-06       Impact factor: 8.194

9.  Acute pericarditis as a primary presentation of COVID-19.

Authors:  Rajesh Kumar; Jathinder Kumar; Caroline Daly; Sadat Ali Edroos
Journal:  BMJ Case Rep       Date:  2020-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.